Corline Biomedical

Corline Biomedical EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Corline Biomedical (CLBIO.ST) as of Oct 10, 2026 is -14.21 M SEK. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -23.07 M SEK — a change of -38.41% (higher).

EBITDA

-14.21 MSEK

YoY

-38.41%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Corline Biomedical is 2025 -14.21 M SEK. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Corline Biomedical was 2024 -23.07 M SEK. It decreases by -38.41% higher compared to the previous year.

The Corline Biomedical EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-6.79 M SEK
Jan 1, 2019
-9.53 M SEK
Jan 1, 2020
-7.26 M SEK
Jan 1, 2021
-6.88 M SEK
Jan 1, 2022
2.39 M SEK
Jan 1, 2023
-1.69 M SEK
Jan 1, 2024
-23.07 M SEK
Jan 1, 2025
-14.21 M SEK
The Corline Biomedical EBITDA history
YEAREBITDAYoY
-14.21 MSEK-38.41%
-23.07 MSEK+1,266.53%
-1.69 MSEK-170.78%
2.39 MSEK-134.68%
-6.88 MSEK-5.27%
-7.26 MSEK-23.82%
-9.53 MSEK+40.33%
-6.79 MSEK-13.01%
-7.81 MSEK+49.64%
-5.22 MSEK-7.62%
-5.65 MSEK+128.86%
-2.47 MSEK—
Access this data via the Eulerpool API
Get Free API Key

Corline Biomedical Stock analysis

What does Corline Biomedical do? Corline Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corline Biomedical stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Corline Biomedical is -14.21 M SEK in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Corline Biomedical changed from -23.07 M SEK to -14.21 M SEK, representing a -38.41% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Corline Biomedical since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Corline Biomedical historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Corline Biomedical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Corline Biomedical